NPT-014

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNPT-014
Drug Alias NameIgG4-Fc GAIM fusion protein (Neurophage)NPT-014
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tauBeta amyloid A4 protein
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProclara Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProclara Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A